The two companies collaborated on research showing quantum computing could greatly aid the design of mRNA-based medicines and ...

While Moderna isn’t looking to replace classical computing with quantum entirely, the company is interested in building a “quantum-enabled biotechnology pipeline.” In conjunction with IBM, the ...

CAMBRIDGE, MA and ARMONK, NY / ACCESSWIRE / April 20, 2023 / Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and IBM (NYSE:IBM ...

Under the collaboration, Moderna will be part of the IBM Quantum Accelerator program as well as the IBM Quantum Network. Per the agreement, IBM will give Moderna access to quantum computing systems ...

Moderna invests in developing quantum computing skills and exploring the use of quantum computing in developing future mRNA medicines Agreement with IBM includes investments in generative AI to ...

The biotechnology and pharmaceutical firm Moderna Inc., best known for its COVID-19 vaccine, said today it’s working with IBM Corp. to explore ways in which quantum computing and generative artifici ...

Garcia noted that Moderna is now part of the IBM Quantum Accelerator program, which provides the opportunity for Moderna scientists to explore how to apply quantum computing toward the development ...

Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and IBM (NYSE:IBM) today announced an agreement under which Moderna will explore ...

Moderna scientists will learn how quantum technology could be applied to previously intractable problems for classical computers. Together, the companies will explore the potential application of ...